Skip to content

Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes

Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01926925
Enrollment
38
Registered
2013-08-21
Start date
2001-05-31
Completion date
2012-02-29
Last updated
2013-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Obesity

Keywords

Type 2 diabetes, Endothelium, children/adolescents

Brief summary

Type 2 diabetes is now more frequent in children/adolescents, especially in those from minority populations, including Hispanic Americans (HA). Diabetes and the pre-diabetes state markedly increase the risk of cardiovascular disease. Endothelial dysfunction is seen in the earliest stages of atherogenesis, which ultimately leads to cardiovascular disease. The main aim of this study is to evaluate the endothelial function in HA children/adolescents who are at risk for developing type 2 diabetes (obese children/adolescents from the Hispanic population). The investigators' hypothesis is that endothelial dysfunction is present in this population and that it is associated with metabolic abnormalities linked to the insulin resistance syndrome. The investigators will study 2 groups of 15 individuals each, age 10-18 years. Group 1 will consist of obese (body mass index greater than 85th percentile for age and sex) Hispanic American children/adolescents and group 2 will consist of healthy, non-overweight (body mass index between the 25th and 50 th percentile for age and sex) Hispanic American children/adolescents. The study will be carried out at the Joslin Diabetes Center. During the first day, participants will have a medical history and full physical examination, a standard OGTT and measurement of blood cell count, plasma glucose, insulin, lipids, HbA1c, BUN, creatinine, electrolytes, estradiol, testosterone, free fatty acids, CRP, endothelial markers, urinary microalbumin and hCG, if appropriate. An OGTT will be performed in order to rule out IGT or Diabetes. Estimations of insulin secretion and insulin sensitivity will be assessed using the homeostasis model assessment (HOMA). In the second day, the body composition and the brachial artery vasodilatory response to hyperemia will be assessed. Those found with diabetes will be tested for GAD-65 and IA2. The investigators' hypothesis is that Hispanic American children/adolescents at risk for type 2 diabetes have impaired endothelial function and vascular reactivity that are associated with the degree of insulin resistance and its metabolic abnormalities.

Detailed description

Information as above

Interventions

None listed

Sponsors

Joslin Diabetes Center
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Group 1: 1. Age between 10-18 years; 2. Hispanic (we will consider a subject being Hispanic if both parents are reported as Hispanics when asked the following question: What ethnic group do you consider that you belong to?); 3. No history of type 2 diabetes in any first-degree relative; 4. Body mass index between the 25th and 50th percentile for age and sex 5. Not have participated in any exercise program for the 6 months prior to the beginning of the study. Group 2: 1. Age between 10-18 years; 2. Hispanic (same criteria as above); 3. Body mass index greater than the 85th percentile for age and sex; 4. Not have participated in any exercise program for the 6 months prior to the beginning of the study.

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frame
Plasma levels of markers of endothelial activation and vascular inflammationcross sectional study - one time evaluation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026